Literature DB >> 30689797

Extracorporeal membrane oxygenation for right ventricular failure following pericardiectomy.

Hasham Ahmad1, Richard Porter2, Hakeem Yusuff2, Marius Roman1.   

Abstract

We report the case of a 61-year-old gentleman who underwent pericardiectomy for constrictive pericarditis. Constrictive pericarditis was diagnosed through echocardiogram, computed tomography chest and cardiac magnetic resonance imaging. An elective decision was made for commencing venoarterial extracorporeal membrane oxygenation (ECMO) immediately postoperatively to prevent significant right ventricular failure (RVF). Postoperatively, the patient remained on ECMO for 4 days in a stable condition, showing no further signs of RVF. Venoarterial ECMO may be of use as an elective adjunct in cases at high risk of RVF following pericardiectomy.
© The Author(s) 2019. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Entities:  

Keywords:  Constrictive pericarditis; Extracorporeal membrane oxygenation; Pericardiectomy; Pericarditis

Mesh:

Year:  2019        PMID: 30689797     DOI: 10.1093/ejcts/ezy491

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  2 in total

1.  The Clinical Efficacy of Cedilanid and Isosorbide Dinitrate plus Pericardial Dissection for Chronic Constrictive Pericarditis in the Elderly and Its Influence on Plasma Endothelin, Atrial Natriuretic Peptide, and Systemic Immune-Inflammation Index.

Authors:  Yan Shao; Zhirong Yang; Lu Yin; Qiang Wang; Jie Wang
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-22       Impact factor: 2.650

2.  Analysis of risk factors of multiorgan failure after pericardiectomy for constrictive pericarditis.

Authors:  Jing-Bin Huang; Zhao-Ke Wen; Jian-Rong Yang; Jun-Jun Li; Min Li; Chang-Chao Lu; Da-Ying Liang; Cheng-Xin Wei
Journal:  J Cardiothorac Surg       Date:  2022-09-30       Impact factor: 1.522

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.